New eye implant could replace daily glaucoma drops

NCT ID NCT07075718

Recruiting now Disease control Sponsor: Glaukos Corporation Source: ClinicalTrials.gov ↗

First seen Feb 28, 2026 · Last updated May 16, 2026 · Updated 9 times

Summary

This study tests a tiny implant placed inside the eye that slowly releases travoprost, a drug that lowers eye pressure. The goal is to see if it works better than daily eye drops for people with open-angle glaucoma or high eye pressure. About 610 adults will take part, and the implant is designed to provide long-term pressure control without needing daily drops.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Glaukos Clinical Site
RECRUITING

El Paso, Texas, 79922, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Glaukos Investigative Site
RECRUITING

Grand Junction, Colorado, 81501, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
Glaukos Investigative Site
RECRUITING

Oklahoma City, Oklahoma, 73112, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

GLAUCOMA